文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

社区卫生工作者促进初级卫生保健可及性(COMPASS):在比利时初级卫生保健中整合综合性社区卫生工作者干预的整群随机对照试验方案

Community Health Workers for Primary Healthcare Access (COMPASS), integrating a comprehensive CHW intervention in primary healthcare in Belgium: a cluster-randomized controlled trial protocol.
PubMed 文献 · Trials · 2025-11-14

COMPASS研究是在比利时安特卫普开展的整群随机对照试验,将18家全科诊所随机分配至干预组或对照组,计划每组诊所纳入21名在获取初级卫生保健方面存在困难者(PECAP),共378名成年PECAP。干预组由社区卫生工作者在12个月内提供家访综合支持,对照组接受标准照护,评估自评健康等指标及成本效果。

要点

  • COMPASS为在比利时安特卫普开展的整群随机对照试验,18家全科诊所随机分配。
  • 计划纳入378名成年PECAP,每家全科诊所拟纳入21名。
  • 干预组社区卫生工作者在12个月内提供家访综合支持,对照组接受标准照护。

核心结论

  • COMPASS整群随机对照试验旨在提供社区卫生工作者与全科诊所合作干预的成本效果、可接受性和可行性的关键证据。
  • 作者认为若被证明有效,该模式可能提供一种可扩展的策略以缓解比利时全国的卫生保健可及性差异。

研究设计与样本

  • COMPASS研究为在比利时安特卫普开展的整群随机对照试验(cRCT),18家全科诊所随机分配至干预组或对照组。
  • 每家全科诊所拟纳入21名PECAP,共计划纳入378名成年PECAP。
  • 研究参与者招募于2024年11月28日开始,于2025年6月11日完成。
  • 研究采用纵向混合方法设计。
  • 将采用整群水平分析以及线性混合模型和广义线性混合模型评估cRCT的有效性。

主要发现

  • 定量研究的主要结局包括自评健康。
  • 次要结局包括卫生保健使用、健康相关生活质量、健康素养、赋权以及卫生保健的经济负担。
  • 将在cRCT同期开展经济评估,评估干预加常规照护与单独标准照护相比的成本效果。
  • 将在两个时间点收集定性数据(深度访谈、焦点小组讨论和参与观察),以评估可接受性和可行性以及影响卫生保健可及性的潜在机制。

临床怎么用

  • 对照组参与者将接受标准照护;干预组社区卫生工作者将在12个月内通过家访,在现行标准照护基础上向处于社会经济弱势状况的个人提供综合支持包。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inequality in access to Primary Health Care (PHC) is increasing in Belgium, in contrast to an overall decreasing trend throughout the European Union. A (cost-)effective solution for access-to-care challenges for people who experience challenges accessing primary healthcare (PECAP) in Belgium is needed; to address this knowledge gap, the research team drew on lessons from the CHW model in the Family Health Strategy (Brazil) and Re-engineering PHC (South Africa), in line with reciprocal innovation, to develop the Community Health Workers for Primary Healthcare Access (COMPASS) intervention. METHODS: The COMPASS study is a cluster-randomized controlled trial (cRCT) in the city of Antwerp, Belgium. Eighteen general practitioner (GP) practices are randomly allocated to the intervention or control arm. In each GP practice, we aim to enrol 21 PECAP, resulting in a total of 378 adult PECAP in the cRCT. Recruitment of study participants commenced on November 28th, 2024, and was completed by June 11th, 2025. In the control arm, participants will receive standard care. In the intervention arm, CHWs will offer a comprehensive package of support in addition to the current standard of care to an individual living in socio-economically vulnerable circumstances during home visits over the course of 12 months. A longitudinal mixed methods design is adopted. To assess the effectiveness of the cRCT, methods including cluster-level analysis as well as linear and generalized linear mixed models will be used. The primary study outcomes of the quantitative research will comprise self-perceived health. Secondary outcomes include health care use, health-related quality of life, health literacy, empowerment, and financial burden of health care. An economic evaluation alongside the cRCT will be conducted to assess the cost-effectiveness of the intervention in addition to usual care, compared to standard care alone. To assess the acceptability and feasibility, as well as the underlying mechanisms of the impact on access to care, qualitative data (in-depth interviews, focus group discussions, and participant observations) will be collected at two time points. DISCUSSION: Via a comprehensive CHW intervention in collaboration with GP practices, the COMPASS cRCT aims to provide crucial evidence on the (cost-)effectiveness, acceptability, and feasibility of an intervention delivered by CHWs linked to GP practices in communities with PECAPs in Belgium. If proven effective, this model may offer a scalable strategy to mitigate healthcare access disparities across Belgium.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Masquillier C, de Beeck EO, Van Iseghem T, et al. Community Health Workers for Primary Healthcare Access (COMPASS), integrating a comprehensive CHW intervention in primary healthcare in Belgium: a cluster-randomized controlled trial protocol. Trials. 2025. PMID: 41239381. doi:10.1186/s13063-025-09205-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。